These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
R
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
|
|
|
For the quarterly period ended March 31, 2010
|
|
|
£
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
|
|
Delaware
|
94-3112828
|
|
(State or other jurisdiction of
|
(I.R.S. Employer
|
|
incorporation or organization)
|
Identification No.)
|
|
Large accelerated filer
R
|
Accelerated filer
£
|
Non-accelerated filer
£
|
Smaller reporting company
£
|
|
(Do not check if a smaller reporting company)
|
|||
|
|
PAGE
|
|||
| 3 | ||||
|
PART I. FINANCIAL INFORMATION
|
||||
|
Item 1. Financial Statements:
|
||||
| 5 | ||||
| 6 | ||||
| 7 | ||||
| 8 | ||||
| 37 | ||||
| 50 | ||||
| 51 | ||||
| 51 | ||||
| 51 | ||||
| 51 | ||||
| 65 | ||||
| 66 | ||||
| 66 | ||||
| 66 | ||||
| 66 | ||||
| 67 | ||||
| 68 | ||||
|
|
•
|
Outcome and effect of current and potential future intellectual property litigation;
|
|
|
•
|
Litigation expenses;
|
|
|
•
|
Protection of intellectual property;
|
|
|
•
|
Amounts owed under licensing agreements;
|
|
|
•
|
Terms of our licenses;
|
|
|
•
|
Acquisitions, mergers or strategic transactions;
|
|
|
•
|
Indemnification and technical support obligations;
|
|
|
•
|
Success in the markets of our or our licensees’ products;
|
|
|
•
|
Sources of competition;
|
|
|
•
|
Operating results;
|
|
|
•
|
Research and development costs and improvements in technology;
|
|
|
•
|
Sources, amounts and concentration of revenue, including royalties;
|
|
|
•
|
Effects of changes in the economy and credit market on our industry and business;
|
|
|
•
|
Deterioration of financial health of commercial counterparties and their ability to meet their obligations to us;
|
|
|
•
|
Restructuring activities;
|
|
|
•
|
Growth in our business;
|
|
|
•
|
Product development;
|
|
|
•
|
Pricing policies of our licensees;
|
|
|
•
|
Success in renewing license agreements;
|
|
|
•
|
Engineering, marketing and general and administration expenses;
|
|
|
•
|
Contract revenue;
|
|
|
•
|
International licenses and operations, including our design facility in Bangalore, India;
|
|
|
•
|
Issuances of our securities, which could involve restrictive covenants or be dilutive to our existing stockholders;
|
|
|
•
|
Repurchases of our Common Stock pursuant to share repurchase programs;
|
|
|
•
|
Effective tax rates;
|
|
|
•
|
Realization of deferred tax assets/release of deferred tax valuation allowance;
|
|
|
•
|
Methods, estimates and judgments in accounting policies;
|
|
|
•
|
Adoption of new accounting pronouncements;
|
|
|
•
|
Ability to identify, attract, motivate and retain qualified personnel;
|
|
|
•
|
Trading price of our Common Stock;
|
|
|
•
|
Corporate governance;
|
|
|
•
|
Consequences of the lawsuits related to the stock option investigation;
|
|
|
•
|
The level and terms of our outstanding debt;
|
|
|
•
|
Resolution of the governmental agency matters involving us;
|
|
|
•
|
Internal control environment;
|
|
|
•
|
Interest and other income, net; and
|
|
|
•
|
Likelihood of paying dividends or repurchasing stock.
|
|
|
March 31,
2010
|
December 31,
2009
|
||||||
|
(In thousands, except shares
|
||||||||
|
and par value)
|
||||||||
|
ASSETS
|
||||||||
|
Current assets:
|
||||||||
|
Cash and cash equivalents
|
$ | 400,921 | $ | 289,073 | ||||
|
Marketable securities
|
267,752 | 171,120 | ||||||
|
Accounts receivable
|
470 | 949 | ||||||
|
Prepaids and other current assets
|
8,662 | 8,700 | ||||||
|
Deferred taxes
|
587 | 129 | ||||||
|
Total current assets
|
678,392 | 469,971 | ||||||
|
Restricted cash
|
661 | 639 | ||||||
|
Deferred taxes, long-term
|
1,604 | 2,034 | ||||||
|
Intangible assets, net
|
22,105 | 21,660 | ||||||
|
Property and equipment, net
|
37,972 | 38,966 | ||||||
|
Goodwill
|
15,554 | 15,554 | ||||||
|
Other assets
|
6,579 | 7,045 | ||||||
|
Total assets
|
$ | 762,867 | $ | 555,869 | ||||
|
LIABILITIES
|
||||||||
|
Current liabilities:
|
||||||||
|
Accounts payable
|
$ | 8,417 | $ | 8,972 | ||||
|
Accrued salaries and benefits
|
14,136 | 6,435 | ||||||
|
Accrued litigation expenses
|
4,555 | 5,147 | ||||||
|
Income taxes payable
|
3,313 | 486 | ||||||
|
Non-cash obligation for construction in progress
|
25,900 | 25,100 | ||||||
|
Other accrued liabilities
|
7,386 | 4,020 | ||||||
|
Convertible notes
|
— | 136,032 | ||||||
|
Total current liabilities
|
63,707 | 186,192 | ||||||
|
Convertible notes
|
114,757 | 112,012 | ||||||
|
Long-term income taxes payable
|
2,042 | 1,994 | ||||||
|
Other long-term liabilities
|
683 | 344 | ||||||
|
Total liabilities
|
181,189 | 300,542 | ||||||
|
Commitments and contingencies
|
||||||||
|
Contingently redeemable common stock:
|
||||||||
|
Outstanding: 4,788,125 shares at March 31, 2010 and no shares at December 31, 2009
|
113,500 | — | ||||||
|
STOCKHOLDERS’ EQUITY
|
||||||||
|
Convertible preferred stock, $.001 par value:
|
||||||||
|
Authorized: 5,000,000 shares
|
||||||||
|
Issued and outstanding: no shares at March 31, 2010 and December 31, 2009
|
— | — | ||||||
|
Common stock, $.001 par value:
|
||||||||
|
Authorized: 500,000,000 shares
|
||||||||
|
Issued and outstanding: 109,786,794 shares at March 31, 2010 and 105,934,157 shares at December 31, 2009
|
110 | 106 | ||||||
|
Additional paid-in capital
|
903,733 | 818,992 | ||||||
|
Accumulated deficit
|
(435,427 | ) | (563,858 | ) | ||||
|
Accumulated other comprehensive income (loss), net
|
(238 | ) | 87 | |||||
|
Total stockholders’ equity
|
468,178 | 255,327 | ||||||
|
Total liabilities, contingently redeemable common stock and stockholders’ equity
|
$ | 762,867 | $ | 555,869 | ||||
|
|
Three Months Ended
March 31,
|
|||||||
|
2010
|
2009
|
|||||||
|
(In thousands, except per
|
||||||||
|
share amounts)
|
||||||||
|
Revenue:
|
||||||||
|
Royalties
|
$ | 160,542 | $ | 26,169 | ||||
|
Contract revenue
|
1,322 | 1,165 | ||||||
|
Total revenue
|
161,864 | 27,334 | ||||||
|
Costs and expenses:
|
||||||||
|
Cost of revenue*
|
1,854 | 2,183 | ||||||
|
Research and development*
|
21,691 | 17,837 | ||||||
|
Marketing, general and administrative*
|
31,527 | 37,156 | ||||||
|
Costs (recoveries) of restatement and related legal activities
|
526 | (13,639 | ) | |||||
|
Gain from settlement
|
(95,900 | ) | — | |||||
|
Total costs and expenses (recoveries)
|
(40,302 | ) | 43,537 | |||||
|
Operating income (loss)
|
202,166 | (16,203 | ) | |||||
|
Interest income and other income (expense), net
|
425 | 1,440 | ||||||
|
Interest expense
|
(6,016 | ) | (2,670 | ) | ||||
|
Interest and other income (expense), net
|
(5,591 | ) | (1,230 | ) | ||||
|
Income (loss) before income taxes
|
196,575 | (17,433 | ) | |||||
|
Provision for (benefit from) income taxes
|
45,676 | (7 | ) | |||||
|
Net income (loss)
|
$ | 150,899 | $ | (17,426 | ) | |||
|
Net income (loss) per share:
|
||||||||
|
Basic
|
$ | 1.33 | $ | (0.17 | ) | |||
|
Diluted
|
$ | 1.28 | $ | (0.17 | ) | |||
|
Weighted average shares used in per share calculation:
|
||||||||
|
Basic
|
113,132 | 104,376 | ||||||
|
Diluted
|
117,463 | 104,376 | ||||||
|
Cost of revenue
|
$ | 100 | $ | 390 | ||||
|
Research and development
|
$ | 2,569 | $ | 2,740 | ||||
|
Marketing, general and administrative
|
$ | 5,165 | $ | 5,289 |
|
|
Three Months Ended
March 31,
|
|||||||
|
|
2010
|
2009
|
||||||
|
(In thousands)
|
||||||||
|
Cash flows from operating activities:
|
||||||||
|
Net income (loss)
|
$ | 150,899 | $ | (17,426 | ) | |||
|
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
|
||||||||
|
Stock-based compensation
|
7,834 | 8,419 | ||||||
|
Depreciation
|
2,473 | 2,807 | ||||||
|
Amortization of intangible assets
|
1,086 | 806 | ||||||
|
Non-cash interest expense and amortization of convertible debt issuance costs
|
3,860 | 2,670 | ||||||
|
Deferred tax (benefit) provision
|
(29 | ) | 95 | |||||
|
Impairment of investments
|
— | 164 | ||||||
|
Change in assets and liabilities:
|
||||||||
|
Accounts receivable
|
479 | 316 | ||||||
|
Prepaids and other assets
|
26 | 1,185 | ||||||
|
Accounts payable
|
(639 | ) | 8,647 | |||||
|
Accrued salaries and benefits and other accrued liabilities
|
9,248 | (1,066 | ) | |||||
|
Accrued litigation expenses
|
(592 | ) | (6,970 | ) | ||||
|
Income taxes payable
|
2,875 | (279 | ) | |||||
|
Increase in restricted cash
|
(22 | ) | (5 | ) | ||||
|
Net cash provided by (used in) operating activities
|
177,498 | (637 | ) | |||||
|
Cash flows from investing activities:
|
||||||||
|
Purchases of property and equipment
|
(534 | ) | (708 | ) | ||||
|
Purchases of marketable securities
|
(136,519 | ) | (83,508 | ) | ||||
|
Maturities of marketable securities
|
39,562 | 90,493 | ||||||
|
Acquisition of intangible assets
|
— | (1,550 | ) | |||||
|
Net cash provided by (used in) investing activities
|
(97,491 | ) | 4,727 | |||||
|
Cash flows from financing activities:
|
||||||||
|
Payments under installment payment arrangement
|
(400 | ) | — | |||||
|
Proceeds received from issuance of contingently redeemable common stock and common stock pursuant to the settlement agreement with Samsung
|
192,000 | — | ||||||
|
Proceeds received from issuance of common stock under employee stock plans
|
3,664 | 5,507 | ||||||
|
Repayment of convertible senior notes
|
(136,950 | ) | — | |||||
|
Repurchase and retirement of common stock
|
(26,473 | ) | — | |||||
|
Net cash provided by financing activities
|
31,841 | 5,507 | ||||||
|
Net increase in cash and cash equivalents
|
111,848 | 9,597 | ||||||
|
Cash and cash equivalents at beginning of period
|
289,073 | 116,241 | ||||||
|
Cash and cash equivalents at end of period
|
$ | 400,921 | $ | 125,838 | ||||
|
Non-cash investing and financing activities:
|
||||||||
|
Intangible assets acquired under installment payment arrangement
|
$ | 1,531 | $ | — | ||||
|
Increase in non-cash obligation for construction in progress
|
$ | 800 | $ | — | ||||
|
2.
|
Summary of Significant Accounting Policies
|
|
(in millions)
|
Estimated Fair
Value
|
|||
|
Settlement Agreement:
|
||||
|
Antitrust litigation settlement
|
$ | 85.0 | ||
|
Settlement of past infringement
|
190.0 | |||
|
License Agreement
|
385.0 | |||
|
Stock Purchase Agreement
|
192.0 | |||
|
Memorandum of understanding (“MOU”)
|
— | |||
|
Residual value
|
48.0 | |||
|
Total
|
$ | 900.0 | ||
|
|
·
|
$575.0 million as revenue which represented the estimated Fair Value of the settlement of past infringement ($190.0 million) from the resolution of the infringement litigation and the patent license agreement ($385.0 million);
|
|
|
·
|
$133.0 million to gain from settlement which represented the Fair Value of the resolution of the antitrust litigation ($85.0 million) and the residual value of other elements ($48.0 million) where specific fair value could not be determined, which included other claims and counter claims released;
|
|
|
·
|
$192.0 million related to the Stock Purchase Agreement which included contingently redeemable common stock due to the restrictions and contractual put rights associated with those shares ($113.5 million) and restricted common stock issued to Samsung ($78.5 million).
|
| Q1 2010 |
Remainder
of 2010
|
2011
|
2012
|
2013
|
2014
|
Estimated Fair
Value
|
||||||||||||||||||||||
|
(in millions)
|
||||||||||||||||||||||||||||
|
Revenue
|
$ | 137.1 | $ | 44.1 | $ | 93.8 | $ | 100.0 | $ | 100.0 | $ | 100.0 | $ | 575.0 | ||||||||||||||
|
Gain from settlement
|
95.9 | 30.9 | 6.2 | — | — | — | 133.0 | |||||||||||||||||||||
|
Purchase of Rambus
Common Stock
|
192.0 | — | — | — | — | — | 192.0 | |||||||||||||||||||||
|
Total
|
$ | 425.0 | $ | 75.0 | $ | 100.0 | $ | 100.0 | $ | 100.0 | $ | 100.0 | $ | 900.0 | ||||||||||||||
|
|
Three Months Ended
March 31,
|
|||||||
|
(In thousands)
|
2010
|
2009
|
||||||
|
Net income (loss)
|
$ | 150,899 | $ | (17,426 | ) | |||
|
Other comprehensive loss:
|
||||||||
|
Unrealized loss on marketable securities, net of tax
|
(325 | ) | (537 | ) | ||||
|
Total comprehensive income (loss)
|
$ | 150,574 | $ | (17,963 | ) | |||
|
|
Shares Available
for Grant
|
|||
|
Shares available as of December 31, 2009
|
7,462,394 | |||
|
Stock options granted
|
(1,586,973 | ) | ||
|
Stock options forfeited
|
17,747 | |||
|
Stock options expired under former plans
|
(1,501 | ) | ||
|
Nonvested equity stock and stock units granted (1)
|
(256,404 | ) | ||
|
Total available for grant as of March 31, 2010
|
5,635,263 | |||
|
(1)
|
For purposes of determining the number of shares available for grant under the 2006 Plan against the maximum number of shares authorized, each restricted stock granted reduces the number of shares available for grant by 1.5 shares and each restricted stock forfeited increases shares available for grant by 1.5 shares.
|
|
|
Options Outstanding
|
|
|
|||||||||||||
|
|
Number of
Shares
|
Weighted
Average
Exercise Price
Per Share
|
Weighted
Average
Remaining
Contractual
Term
|
Aggregate
Intrinsic
Value
|
||||||||||||
|
(Dollars in thousands, except per share amounts)
|
||||||||||||||||
|
Outstanding as of December 31, 2009
|
14,456,110 | $ | 20.95 | |||||||||||||
|
Options granted
|
1,586,973 | 22.83 | ||||||||||||||
|
Options exercised
|
(227,460 | ) | 14.83 | |||||||||||||
|
Options forfeited
|
(17,747 | ) | 17.47 | |||||||||||||
|
Outstanding as of March 31, 2010
|
15,797,876 | 21.23 | 5.61 | $ | 72,682 | |||||||||||
|
Vested or expected to vest at March 31, 2010
|
14,977,777 | 21.61 | 5.54 | 66,117 | ||||||||||||
|
Options exercisable at March 31, 2010
|
10,550,502 | 22.88 | 4.40 | 48,092 | ||||||||||||
|
|
Three Months Ended
March 31,
|
|||||||
|
|
2010
|
2009
|
||||||
|
Stock Option Plans
|
||||||||
|
Expected stock price volatility
|
61 | % | 96 | % | ||||
|
Risk free interest rate
|
2.44 | % | 1.76 | % | ||||
|
Expected term (in years)
|
5.9 | 5.3 | ||||||
|
Weighted-average fair value of stock options granted
|
$ | 13.18 | $ | 6.38 | ||||
|
Nonvested Equity Stock and Stock Units
|
Shares
|
Weighted-
Average
Grant-Date
Fair Value
|
||||||
|
Nonvested at December 31, 2009
|
783,976 | $ | 16.24 | |||||
|
Granted
|
170,936 | 22.72 | ||||||
|
Vested
|
(111,977 | ) | 14.92 | |||||
|
Forfeited
|
— | — | ||||||
|
Nonvested at March 31, 2010
|
842,935 | $ | 17.73 | |||||
|
March 31, 2010
|
||||||||||||||||||||
|
(in thousands)
|
Fair Value
|
Book Value
|
Gross
Unrealized
Gains
|
Gross
Unrealized
Losses
|
Weighted
Rate of
Return
|
|||||||||||||||
|
Money Market Funds
|
$ | 396,702 | $ | 396,702 | $ | — | $ | — | 0.01 | % | ||||||||||
|
U.S. Government Bonds and Notes
|
236,578 | 236,543 | 209 | (174 | ) | 0.66 | % | |||||||||||||
|
Corporate Notes, Bonds and Commercial Paper
|
31,174 | 31,158 | 36 | (20 | ) | 0.74 | % | |||||||||||||
|
Total cash equivalents and marketable securities
|
664,454 | 664,403 | 245 | (194 | ) | |||||||||||||||
|
Cash
|
4,219 | 4,219 | — | — | ||||||||||||||||
|
Total cash, cash equivalents and marketable securities
|
$ | 668,673 | $ | 668,622 | $ | 245 | $ | (194 | ) | |||||||||||
|
December 31, 2009
|
||||||||||||||||||||
|
(in thousands)
|
Fair Value
|
Book Value
|
Gross
Unrealized
Gains
|
Gross
Unrealized
Losses
|
Weighted
Rate of
Return
|
|||||||||||||||
|
Money Market Funds
|
$ | 280,908 | $ | 280,908 | $ | — | $ | — | 0.01 | % | ||||||||||
|
U.S. Government Bonds and Notes
|
138,829 | 138,521 | 377 | (69 | ) | 1.09 | % | |||||||||||||
|
Corporate Notes, Bonds and Commercial Paper
|
32,291 | 32,222 | 70 | (1 | ) | 1.89 | % | |||||||||||||
|
Total cash equivalents and marketable securities
|
452,028 | 451,651 | 447 | (70 | ) | |||||||||||||||
|
Cash
|
8,165 | 8,165 | — | — | ||||||||||||||||
|
Total cash, cash equivalents and marketable securities
|
$ | 460,193 | $ | 459,816 | $ | 447 | $ | (70 | ) | |||||||||||
|
|
March 31,
2010
|
December 31,
2009
|
||||||
|
(in thousands)
|
||||||||
|
Cash equivalents
|
$ | 396,702 | $ | 280,908 | ||||
|
Short term marketable securities
|
267,752 | 171,120 | ||||||
|
Total cash equivalents and marketable securities
|
664,454 | 452,028 | ||||||
|
Cash
|
4,219 | 8,165 | ||||||
|
Total cash, cash equivalents and marketable securities
|
$ | 668,673 | $ | 460,193 | ||||
|
|
As of
|
Unrealized Gain, net
|
||||||||||||||
|
|
March 31,
2010
|
December 31,
2009
|
March 31,
2010
|
December 31,
2009
|
||||||||||||
|
(in thousands)
|
||||||||||||||||
|
Contractual maturity:
|
||||||||||||||||
|
Due within one year
|
$ | 655,953 | $ | 419,054 | $ | 50 | $ | 250 | ||||||||
|
Due from one year through three years
|
8,501 | 32,974 | 1 | 127 | ||||||||||||
| $ | 664,454 | $ | 452,028 | $ | 51 | $ | 377 | |||||||||
|
(in thousands)
|
Total
|
Remainder
of 2010
|
2011
|
2012
|
2013
|
2014
|
Thereafter
|
|||||||||||||||||||||
|
Contractual obligations
(1)
|
||||||||||||||||||||||||||||
|
Leases (2)
|
$ | 51,740 | $ | 7,197 | $ | 5,163 | $ | 5,197 | $ | 4,477 | $ | 4,580 | $ | 25,126 | ||||||||||||||
|
Convertible notes
|
172,500 | — | — | — | — | 172,500 | — | |||||||||||||||||||||
|
Interest payments related
to convertible notes
|
36,276 | 6,469 | 8,625 | 8,625 | 8,625 | 3,932 | — | |||||||||||||||||||||
|
Total
|
$ | 260,516 | $ | 13,666 | $ | 13,788 | $ | 13,822 | $ | 13,102 | $ | 181,012 | $ | 25,126 | ||||||||||||||
|
(1)
|
The above table does not reflect possible payments in connection with uncertain tax benefits of approximately $10.5 million, including $8.5 million recorded as a reduction of long-term deferred tax assets and $2.0 million in long-term income taxes payable, as of March 31, 2010. As noted below in Note 10, “Income Taxes,” although it is possible that some of the unrecognized tax benefits could be settled within the next 12 months, the Company cannot reasonably estimate the outcome at this time.
|
|
(2)
|
Includes both the Sunnyvale Lease and Ohio Lease.
|
|
|
·
|
$113.5 million related to 4.8 million shares treated as contingently redeemable common stock due to the contractual put rights associated with those shares
|
|
|
·
|
$78.5 million related to the remaining 4.8 million shares treated as stockholders’ equity
|
|
|
Three Months Ended March 31,
|
|||||||||||||||
|
2010
|
2009
|
|||||||||||||||
|
(In thousands, except per share amounts)
|
||||||||||||||||
|
CRCS*
|
Other CS**
|
CRCS*
|
Other CS**
|
|||||||||||||
|
Basic net income (loss) per share:
|
||||||||||||||||
|
Numerator:
|
||||||||||||||||
|
Allocation of undistributed earnings
|
$ | 5,109 | $ | 145,790 | $ | — | $ | (17,426 | ) | |||||||
|
Denominator:
|
||||||||||||||||
|
Weighted-average common shares outstanding
|
3,830 | 109,302 | — | 104,376 | ||||||||||||
|
Basic net income (loss) per share
|
$ | 1.33 | $ | 1.33 | $ | — | $ | (0.17 | ) | |||||||
|
Diluted net income (loss) per share:
|
||||||||||||||||
|
Numerator:
|
||||||||||||||||
|
Allocation of undistributed earnings for basic computation
|
$ | 5,109 | $ | 145,790 | $ | — | $ | (17,426 | ) | |||||||
|
Reallocation of undistributed earnings
|
(188 | ) | 188 | — | — | |||||||||||
|
Allocation of undistributed earnings for diluted computation
|
$ | 4,921 | $ | 145,978 | $ | — | $ | (17,426 | ) | |||||||
|
Denominator:
|
||||||||||||||||
|
Number of shares used in basic computation
|
3,830 | 109,302 | — | 104,376 | ||||||||||||
|
Dilutive potential shares from stock options, ESPP, Convertible notes and nonvested equity stock and stock units
|
— | 4,331 | — | — | ||||||||||||
|
Number of shares used in diluted computation
|
3,830 | 113,633 | — | 104,376 | ||||||||||||
|
Diluted net income (loss) per share
|
$ | 1.28 | $ | 1.28 | $ | — | $ | (0.17 | ) | |||||||
|
12.
|
Business Segments, Exports and Major Customers
|
|
|
Three Months Ended
March 31,
|
|||||||
|
(In thousands)
|
2010
|
2009
|
||||||
|
Japan
|
$ | 19,036 | $ | 21,811 | ||||
|
North America
|
5,485 | 5,268 | ||||||
|
Taiwan
|
45 | 23 | ||||||
|
Korea
|
137,166 | 142 | ||||||
|
Singapore
|
— | 43 | ||||||
|
Europe
|
132 | 47 | ||||||
| $ | 161,864 | $ | 27,334 | |||||
|
As of March 31, 2010
|
||||||||||||
|
|
Gross Carrying
Amount
|
Accumulated
Amortization
|
Net Carrying
Amount
|
|||||||||
|
(In thousands)
|
||||||||||||
|
Patents
|
$ | 13,973 | $ | (7,285 | ) | $ | 6,688 | |||||
|
Intellectual property
|
10,384 | (10,384 | ) | — | ||||||||
|
Customer contracts and contractual relationships
|
4,050 | (2,852 | ) | 1,198 | ||||||||
|
Existing technology
|
17,550 | (3,331 | ) | 14,219 | ||||||||
|
Non-competition agreement
|
100 | (100 | ) | — | ||||||||
|
Total intangible assets
|
$ | 46,057 | $ | (23,952 | ) | $ | 22,105 | |||||
|
As of December 31, 2009
|
||||||||||||
|
|
Gross Carrying
Amount
|
Accumulated
Amortization
|
Net Carrying
Amount
|
|||||||||
|
(In thousands)
|
||||||||||||
|
Patents
|
$ | 12,441 | $ | (6,876 | ) | $ | 5,565 | |||||
|
Intellectual property
|
10,384 | (10,384 | ) | — | ||||||||
|
Customer contracts and contractual relationships
|
4,050 | (2,717 | ) | 1,333 | ||||||||
|
Existing technology
|
17,550 | (2,788 | ) | 14,762 | ||||||||
|
Non-competition agreement
|
100 | (100 | ) | — | ||||||||
|
Total intangible assets
|
$ | 44,525 | $ | (22,865 | ) | $ | 21,660 | |||||
|
Years Ending December 31:
|
Amount
|
|||
|
2010 (remaining 9 months)
|
$ | 3,289 | ||
|
2011
|
4,054 | |||
|
2012
|
3,781 | |||
|
2013
|
3,475 | |||
|
2014
|
2,574 | |||
|
Thereafter
|
4,932 | |||
| $ | 22,105 | |||
|
|
As of March 31, 2010
|
|||||||||||||||
|
|
Total
|
Quoted
Market
Prices in
Active
Markets
(Level 1)
|
Significant
Other
Observable
Inputs
(Level 2)
|
Significant
Unobservable
Inputs
(Level 3)
|
||||||||||||
|
(In thousands)
|
||||||||||||||||
|
Money market funds
|
$ | 396,702 | $ | 396,702 | $ | — | $ | — | ||||||||
|
U.S. government bonds and notes
|
236,578 | — | 236,578 | — | ||||||||||||
|
Corporate notes, bonds and commercial paper
|
31,174 | — | 31,174 | — | ||||||||||||
|
Total available-for-sale debt securities
|
$ | 664,454 | $ | 396,702 | $ | 267,752 | $ | — | ||||||||
|
As of December 31, 2009
|
||||||||||||||||
|
|
Total
|
Quoted
Market
Prices in
Active
Markets
(Level 1)
|
Significant
Other
Observable
Inputs
(Level 2)
|
Significant
Unobservable
Inputs
(Level 3)
|
||||||||||||
|
(In thousands)
|
||||||||||||||||
|
Money market funds
|
$ | 280,908 | $ | 280,908 | $ | — | $ | — | ||||||||
|
U.S. government bonds and notes
|
138,829 | — | 138,829 | — | ||||||||||||
|
Corporate notes, bonds and commercial paper
|
32,291 | — | 32,291 | — | ||||||||||||
|
Total available-for-sale debt securities
|
$ | 452,028 | $ | 280,908 | $ | 171,120 | $ | — | ||||||||
|
As of March 31, 2010
|
||||||||||||||||||||
|
(in thousands)
|
Carrying
Value
|
Quoted
Market
Prices in
Active
Markets
(Level 1)
|
Significant
Other
Observable
Inputs
(Level 2)
|
Significant
Unobservable
Inputs
(Level 3)
|
Impairment Charges for the Three Months Ended March 31,
2010
|
|||||||||||||||
|
Investment in non-marketable security
|
$ | 2,000 | $ | — | $ | — | $ | 2,000 | $ | — | ||||||||||
|
As of December 31, 2009
|
||||||||||||||||||||
|
(in thousands)
|
Carrying
Value
|
Quoted
Market
Prices in
Active
Markets
(Level 1)
|
Significant
Other
Observable
Inputs
(Level 2)
|
Significant
Unobservable
Inputs
(Level 3)
|
Impairment Charges
for the
Year
Ended
December 31,
2009
|
|||||||||||||||
|
Investment in non-marketable security
|
$ | 2,000 | $ | — | $ | — | $ | 2,000 | $ | — | ||||||||||
|
|
As of March 31, 2010
|
As of December 31, 2009
|
||||||||||||||||||||||
|
(in thousands)
|
Face
Value
|
Carrying
Value
|
Fair Value
|
Face
Value
|
Carrying
Value
|
Fair Value
|
||||||||||||||||||
|
5% Convertible Senior Notes due 2014
|
$ | 172,500 | $ | 114,757 | $ | 237,840 | $ | 172,500 | $ | 112,012 | $ | 261,160 | ||||||||||||
|
Zero Coupon Convertible Senior Notes due 2010
|
— | — | — | 136,950 | 136,032 | 142,599 | ||||||||||||||||||
|
Total Convertible notes
|
$ | 172,500 | $ | 114,757 | $ | 237,840 | $ | 309,450 | $ | 248,044 | $ | 403,759 | ||||||||||||
|
(in thousands)
|
As of
March 31,
2010
|
As of
December 31,
2009
|
||||||
|
5% Convertible Senior Notes due 2014
|
$ | 172,500 | $ | 172,500 | ||||
|
Zero Coupon Convertible Senior Notes due 2010
|
— | 136,950 | ||||||
|
Total principal amount of convertible notes
|
172,500 | 309,450 | ||||||
|
Unamortized discount
|
(57,743 | ) | (61,406 | ) | ||||
|
Total convertible notes
|
$ | 114,757 | $ | 248,044 | ||||
|
Less current portion
|
— | (136,032 | ) | |||||
|
Total long-term convertible notes
|
$ | 114,757 | $ | 112,012 | ||||
|
|
(1)
|
default in the payment when due of any principal of any of the 2014 Notes at maturity, upon redemption or upon exercise of a repurchase right or otherwise;
|
|
|
(2)
|
default in the payment of any interest, including additional interest, if any, on any of the 2014 Notes, when the interest becomes due and payable, and continuance of such default for a period of 30 days;
|
|
|
(3)
|
the Company’s failure to deliver cash or cash and shares of Common Stock (including any additional shares deliverable as a result of a conversion in connection with a make-whole fundamental change) when required to be delivered upon the conversion of any 2014 Note;
|
|
|
(4)
|
default in the Company’s obligation to provide notice of the occurrence of a fundamental change when required by the Indenture;
|
|
|
(5)
|
the Company’s failure to comply with any of its other agreements in the 2014 Notes or the Indenture (other than those referred to in clauses (1) through (4) above) for 60 days after the Company’s receipt of written notice to the Company of such default from the trustee or to the Company and the trustee of such default from holders of not less than 25% in aggregate principal amount of the 2014 Notes then outstanding;
|
|
|
(6)
|
the Company’s failure to pay when due the principal of, or acceleration of, any indebtedness for money borrowed by the Company or any of its subsidiaries in excess of $30,000,000 principal amount, if such indebtedness is not discharged, or such acceleration is not annulled, by the end of a period of ten days after written notice to the Company by the trustee or to the Company and the trustee by the holders of at least 25% in aggregate principal amount of the 2014 Notes then outstanding; and
|
|
|
(7)
|
certain events of bankruptcy, insolvency or reorganization relating to the Company or any of its material subsidiaries (as defined in the Indenture).
|
|
|
•
|
cash in an amount equal to the lesser of
|
|
|
(1)
|
the principal amount of each note to be converted and
|
|
|
(2)
|
the “conversion value,” which is equal to (a) the applicable conversion rate, multiplied by (b) the applicable stock price, as defined.
|
|
|
•
|
if the conversion value is greater than the principal amount of each note, a number of shares of Rambus Common Stock (the “net shares”) equal to the sum of the daily share amounts, calculated as defined. However, in lieu of delivering net shares, Rambus, at its option, may deliver cash, or a combination of cash and shares of its Common Stock, with a value equal to the net shares amount.
|
|
|
Three Months Ended
March 31,
|
|||||||
|
|
2010
|
2009
|
||||||
|
(in thousands)
|
||||||||
|
2014 Notes coupon interest at a rate of 5%
|
$ | 2,156 | $ | — | ||||
|
2014 Notes amortization of discount at an additional effective interest rate of 11.7%
|
2,902 | — | ||||||
|
2010 Notes amortization of discount at an effective interest rate of 8.4%
|
958 | 2,670 | ||||||
|
Total interest expense
|
$ | 6,016 | $ | 2,670 | ||||
|
Double Data Rate
|
DDR
|
|
Dynamic Random Access Memory
|
DRAM
|
|
Fully Buffered-Dual Inline Memory Module
|
FB-DIMM
|
|
Gigabits per second
|
Gb/s
|
|
Graphics Double Data Rate
|
GDDR
|
|
Input/Output
|
I/O
|
|
Lighting and Display Technology
|
LDT
|
|
Peripheral Component Interconnect
|
PCI
|
|
Rambus Dynamic Random Access Memory
|
RDRAM
tm
|
|
Single Data Rate
|
SDR
|
|
Synchronous Dynamic Random Access Memory
|
SDRAM
|
|
eXtreme Data Rate
|
XDR
tm
|
|
Advanced Micro Devices Inc.
|
AMD
|
|
ARM Holdings plc
|
ARM
|
|
Elpida Memory, Inc.
|
Elpida
|
|
Fujitsu Limited
|
Fujitsu
|
|
Global Lighting Technologies, Inc.
|
GLT
|
|
Hewlett-Packard Company
|
Hewlett-Packard
|
|
Hynix Semiconductor, Inc.
|
Hynix
|
|
Infineon Technologies AG
|
Infineon
|
|
Inotera Memories, Inc.
|
Inotera
|
|
Intel Corporation
|
Intel
|
|
International Business Machines Corporation
|
IBM
|
|
Joint Electronic Device Engineering Councils
|
JEDEC
|
|
Micron Technologies, Inc.
|
Micron
|
|
Nanya Technology Corporation
|
Nanya
|
|
NEC Electronics Corporation
|
NEC
|
|
NVIDIA Corporation
|
NVIDIA
|
|
Optical Internetworking Forum
|
OIF
|
|
Qimonda AG (formerly Infineon’s DRAM operations)
|
Qimonda
|
|
Panasonic Corporation
|
Panasonic
|
|
Peripheral Component Interconnect — Special Interest Group
|
PCI-SIG
|
|
Renesas Technology Corporation
|
Renesas
|
|
Samsung Electronics Co., Ltd.
|
Samsung
|
|
Sony Computer Electronics
|
Sony
|
|
Spansion, Inc.
|
Spansion
|
|
Texas Instruments Inc.
|
Texas Instruments
|
|
Toshiba Corporation
|
Toshiba
|
|
|
Three Months Ended
March 31,
|
|||||||
|
|
2010
|
2009
|
||||||
|
Revenue:
|
||||||||
|
Royalties
|
99.2 | % | 95.7 | % | ||||
|
Contract revenue
|
0.8 | % | 4.3 | % | ||||
|
Total revenue
|
100.0 | % | 100.0 | % | ||||
|
Costs and expenses:
|
||||||||
|
Cost of revenue*
|
1.1 | % | 8.0 | % | ||||
|
Research and development*
|
13.4 | % | 65.3 | % | ||||
|
Marketing, general and administrative*
|
19.5 | % | 135.9 | % | ||||
|
Costs (recoveries) of restatement and related legal activities
|
0.3 | % | (49.9 | )% | ||||
|
Gain from settlement
|
(59.2 | )% | — | % | ||||
|
Total costs and expenses (recoveries)
|
(24.9 | )% | 159.3 | % | ||||
|
Operating income (loss)
|
124.9 | % | (59.3 | )% | ||||
|
Interest income and other income (expense), net
|
0.3 | % | 5.3 | % | ||||
|
Interest expense
|
(3.7 | )% | (9.8 | )% | ||||
|
Interest and other income (expense), net
|
(3.5 | )% | (4.5 | )% | ||||
|
Income (loss) before income taxes
|
121.4 | % | (63.8 | )% | ||||
|
Provision for (benefit from) income taxes
|
28.2 | % | — | |||||
|
Net income (loss)
|
93.2 | % | (63.8 | )% | ||||
|
Cost of revenue
|
0.1 | % | 1.4 | % | ||||
|
Research and development
|
1.6 | % | 10.0 | % | ||||
|
Marketing, general and administrative
|
3.2 | % | 19.4 | % |
|
|
Three Months
Ended March 31,
|
Change in
|
||||||||||
|
|
2010
|
2009
|
Percentage
|
|||||||||
|
(Dollars in millions)
|
||||||||||||
|
Total Revenue
|
||||||||||||
|
Royalties
|
$ | 160.6 | $ | 26.1 | 513.5 | % | ||||||
|
Contract revenue
|
1.3 | 1.2 | 13.5 | % | ||||||||
|
Total revenue
|
$ | 161.9 | $ | 27.3 | 492.2 | % | ||||||
|
|
Three Months Ended
March 31,
|
Change in
|
||||||||||
|
|
2010
|
2009
|
Percentage
|
|||||||||
|
(Dollars in millions)
|
||||||||||||
|
Engineering costs
|
||||||||||||
|
Cost of revenue
|
$ | 1.8 | $ | 1.8 | (2.2 | )% | ||||||
|
Stock-based compensation
|
0.1 | 0.4 | (74.4 | )% | ||||||||
|
Total cost of revenue
|
1.9 | 2.2 | (15.1 | )% | ||||||||
|
Research and development
|
19.1 | 15.1 | 26.7 | % | ||||||||
|
Stock-based compensation
|
2.6 | 2.7 | (6.2 | )% | ||||||||
|
Total research and development
|
21.7 | 17.8 | 21.6 | % | ||||||||
|
Total engineering costs
|
$ | 23.6 | $ | 20.0 | 17.6 | % | ||||||
|
|
Three Months Ended
March 31,
|
Change in
|
||||||||||
|
|
2010
|
2009
|
Percentage
|
|||||||||
|
(Dollars in millions)
|
||||||||||||
|
Marketing, general and administrative costs
|
||||||||||||
|
Marketing, general and administrative costs
|
$ | 19.3 | $ | 13.9 | 39.2 | % | ||||||
|
Litigation expense
|
7.0 | 18.0 | (60.9 | )% | ||||||||
|
Stock-based compensation
|
5.2 | 5.3 | (2.3 | )% | ||||||||
|
Total marketing, general and administrative costs
|
$ | 31.5 | $ | 37.2 | (15.1 | )% | ||||||
|
|
Three Months Ended
March 31,
|
Change in
|
|||||||
|
|
2010
|
2009
|
Percentage
|
||||||
|
(Dollars in millions)
|
|||||||||
|
Gain from settlement
|
$ | 95.9 | $ | — |
NM*
|
||||
|
|
Three Months Ended
March 31,
|
Change in
|
|||||||
|
|
2010
|
2009
|
Percentage
|
||||||
|
(Dollars in millions)
|
|||||||||
|
Cost (recoveries) of restatement and related legal activities
|
$ | 0.5 | $ | (13.6 | ) |
NM*
|
|||
|
|
Three Months Ended
March 31,
|
Change in
|
||||||||||
|
|
2010
|
2009
|
Percentage
|
|||||||||
|
(Dollars in millions)
|
||||||||||||
|
Interest income and other income, net
|
$ | 0.4 | $ | 1.4 | (70.5 | )% | ||||||
|
Interest expense
|
(6.0 | ) | (2.6 | ) | 125.3 | % | ||||||
|
Interest and other income (expense), net
|
$ | (5.6 | ) | $ | (1.2 | ) |
NM*
|
|||||
|
|
Three Months Ended
March 31,
|
Change in
|
|||||||
|
|
2010
|
2009
|
Percentage
|
||||||
|
(Dollars in millions)
|
|||||||||
|
Provision for (benefit from) income taxes
|
$ | 45.7 | $ | — |
NM*
|
||||
|
Effective tax rate
|
23.2 | % | 0.1 | % | |||||
|
|
March 31,
2010
|
December 31,
2009
|
||||||
|
(In millions)
|
||||||||
|
Cash and cash equivalents
|
$ | 400.9 | $ | 289.1 | ||||
|
Marketable securities
|
267.8 | 171.1 | ||||||
|
Total cash, cash equivalents, and marketable securities
|
$ | 668.7 | $ | 460.2 | ||||
|
|
Three Months Ended
March 31,
|
|||||||
|
|
2010
|
2009
|
||||||
|
(In millions)
|
||||||||
|
Net cash provided by (used in) operating activities
|
$ | 177.5 | $ | (0.6 | ) | |||
|
Net cash provided by (used in) investing activities
|
$ | (97.5 | ) | $ | 4.7 | |||
|
Net cash provided by financing activities
|
$ | 31.8 | $ | 5.5 | ||||
|
(in thousands)
|
Total
|
Remainder
of 2010
|
2011
|
2012
|
2013
|
2014
|
Thereafter
|
|||||||||||||||||||||
|
Contractual obligations(1)
|
||||||||||||||||||||||||||||
|
Leases (2)
|
$ | 51,740 | $ | 7,197 | $ | 5,163 | $ | 5,197 | $ | 4,477 | $ | 4,580 | $ | 25,126 | ||||||||||||||
|
Convertible notes
|
172,500 | — | — | — | — | 172,500 | — | |||||||||||||||||||||
|
Interest payments related to convertible notes
|
36,276 | 6,469 | 8,625 | 8,625 | 8,625 | 3,932 | — | |||||||||||||||||||||
|
Total
|
$ | 260,516 | $ | 13,666 | $ | 13,788 | $ | 13,822 | $ | 13,102 | $ | 181,012 | $ | 25,126 | ||||||||||||||
|
(1)
|
The above table does not reflect possible payments in connection with uncertain tax benefits of approximately $10.5 million, including $8.5 million recorded as a reduction of long-term deferred tax assets and $2.0 million in long-term income taxes payable, as of March 31, 2010. Although it is possible that some of the unrecognized tax benefits could be settled within the next 12 months, the Company cannot reasonably estimate the outcome at this time.
|
|
(2)
|
Includes both the Sunnyvale Lease and Ohio Lease.
|
|
|
·
|
$113.5 million related to 4.8 million shares treated as contingently redeemable common stock due to the contractual put rights associated with those shares
|
|
|
·
|
$78.5 million related to the remaining 4.8 million shares treated as stockholders’ equity
|
|
March 31, 2010
|
||||||||||||||||||||
|
(dollars in thousands)
|
Fair Value
|
Book Value
|
Gross
Unrealized
Gains
|
Gross
Unrealized
Losses
|
Weighted
Rate of
Return
|
|||||||||||||||
|
Money Market Funds
|
$ | 396,702 | $ | 396,702 | $ | — | $ | — | 0.01 | % | ||||||||||
|
U.S. Government Bonds and Notes
|
236,578 | 236,543 | 209 | (174 | ) | 0.66 | % | |||||||||||||
|
Corporate Notes, Bonds and Commercial Paper
|
31,174 | 31,158 | 36 | (20 | ) | 0.74 | % | |||||||||||||
|
Total cash equivalents and marketable securities
|
664,454 | 664,403 | 245 | (194 | ) | |||||||||||||||
|
Cash
|
4,219 | 4,219 | — | — | ||||||||||||||||
|
Total cash, cash equivalents and marketable securities
|
$ | 668,673 | $ | 668,622 | $ | 245 | $ | (194 | ) | |||||||||||
|
December 31, 2009
|
||||||||||||||||||||
|
(dollars in thousands)
|
Fair Value
|
Book Value
|
Gross
Unrealized
Gains
|
Gross
Unrealized
Losses
|
Weighted
Rate of
Return
|
|||||||||||||||
|
Money Market Funds
|
$ | 280,908 | $ | 280,908 | $ | — | $ | — | 0.01 | % | ||||||||||
|
U.S. Government Bonds and Notes
|
138,829 | 138,521 | 377 | (69 | ) | 1.09 | % | |||||||||||||
|
Corporate Notes, Bonds and Commercial Paper
|
32,291 | 32,222 | 70 | (1 | ) | 1.89 | % | |||||||||||||
|
Total cash equivalents and marketable securities
|
452,028 | 451,651 | 447 | (70 | ) | |||||||||||||||
|
Cash
|
8,165 | 8,165 | — | — | ||||||||||||||||
|
Total cash, cash equivalents and marketable securities
|
$ | 460,193 | $ | 459,816 | $ | 447 | $ | (70 | ) | |||||||||||
|
(in thousands)
|
Fair Value
|
Fair Value Given a
10%
Increase
in Market
Prices
|
Fair Value Given a
10%
Decrease
in Market
Prices
|
|||||||||
|
5% Convertible Senior Notes due 2014
|
$ | 237,840 | $ | 261,624 | $ | 214,056 | ||||||
|
|
•
|
competition faced by a company in its particular industry;
|
|
|
•
|
the timely introduction and market acceptance of a company’s products;
|
|
|
•
|
the engineering, sales and marketing and management capabilities of a company;
|
|
|
•
|
technical challenges unrelated to our innovations faced by a company in developing its products;
|
|
|
•
|
the financial and other resources of a company;
|
|
|
•
|
the supply of semiconductors from our memory and chip interface licensees in sufficient quantities and at commercially attractive prices;
|
|
|
•
|
the ability to establish the prices at which the chips containing our chip interfaces are made available to system companies; and
|
|
|
•
|
the degree to which our licensees promote our innovations to their customers.
|
|
|
•
|
completed before changes in the semiconductor industry render them obsolete;
|
|
|
•
|
available when system companies require these innovations; and
|
|
|
•
|
sufficiently compelling to cause semiconductor manufacturers to enter into licensing arrangements with us for these new technologies.
|
|
|
•
|
semiconductor and system companies’ acceptance of our chip interface products;
|
|
|
•
|
the success of high volume consumer applications, such as the Sony PLAYSTATION® 3;
|
|
|
•
|
the dependence of our royalties upon fluctuating sales volumes and prices of licensed chips that include our technology;
|
|
|
•
|
the seasonal shipment patterns of systems incorporating our chip interface products;
|
|
|
•
|
the loss of any strategic relationships with system companies or licensees;
|
|
|
•
|
semiconductor or system companies discontinuing major products incorporating our chip interfaces;
|
|
|
•
|
the unpredictability of litigation results or settlements and the timing and amount of any litigation expenses;
|
|
|
•
|
changes in our customers’ development schedules and levels of expenditure on research and development;
|
|
|
•
|
our licensees terminating or failing to make payments under their current contracts or seeking to modify such contracts, whether voluntarily or as a result of financial difficulties;
|
|
|
•
|
the results of our efforts to expand into new target markets, such as with our Lighting and Display Technology group;
|
|
|
•
|
changes in our strategies, including changes in our licensing focus and/or acquisitions of companies with business models or target markets different from our own; and
|
|
|
•
|
changes in the economy and credit market and their effects upon demand for our technology and the products of our licensees.
|
|
|
•
|
export controls, tariffs, import and licensing restrictions and other trade barriers;
|
|
|
•
|
profits, if any, earned abroad being subject to local tax laws and not being repatriated to the United States or, if repatriation is possible, limited in amount;
|
|
|
•
|
treatment of revenue from international sources and changes to tax codes, including being subject to foreign tax laws and being liable for paying withholding, income or other taxes in foreign jurisdictions;
|
|
|
•
|
foreign government regulations and changes in these regulations;
|
|
|
•
|
social, political and economic instability;
|
|
|
•
|
lack of protection of our intellectual property and other contract rights by jurisdictions in which we may do business to the same extent as the laws of the United States;
|
|
|
•
|
changes in diplomatic and trade relationships;
|
|
|
•
|
cultural differences in the conduct of business both with licensees and in conducting business in our international facilities and international sales offices;
|
|
|
•
|
operating centers outside the United States;
|
|
|
•
|
hiring, maintaining and managing a workforce remotely and under various legal systems; and
|
|
|
•
|
geo-political issues.
|
|
|
•
|
the key personnel of the acquired entity or business may decide not to work for us or may not perform according to our expectations;
|
|
|
•
|
we may experience additional legal, financial and accounting challenges and complexities in areas such as licensing, tax planning, cash management and financial reporting;
|
|
|
•
|
our ongoing business may be disrupted or receive insufficient management attention;
|
|
|
•
|
we may not be able to recognize the financial benefits we anticipated and/or we may suffer losses, both with respect to our ongoing business and the acquired entity or business;
|
|
|
•
|
our increasing international presence resulting from acquisitions may increase our exposure to international currency, tax and political risks; and
|
|
|
•
|
our lack of experience in new markets, products or technologies may cause us to fail to recognize the forecasted financial and strategic benefits of the acquisition.
|
|
|
•
|
new litigation or developments in current litigation, including an unfavorable outcome to us from court proceedings relating to our litigation with Hynix, Micron, Nanya and NVIDIA and reaction to any settlements that we enter into with former litigants, such as Samsung;
|
|
|
•
|
any progress, or lack of progress, real or perceived, in the development of products that incorporate our innovations;
|
|
|
•
|
our signing or not signing new licensees;
|
|
|
•
|
announcements of our technological innovations or new products by us, our licensees or our competitors;
|
|
|
•
|
positive or negative reports by securities analysts as to our expected financial results;
|
|
|
•
|
developments with respect to patents or proprietary rights and other events or factors;
|
|
|
•
|
trading activity related to our share repurchase plans; and
|
|
|
•
|
issuance of additional securities by us, such as our issuance of approximately 9.6 million shares of common stock to Samsung in connection with our settlement agreement in January 2010.
|
|
|
•
|
our ability to obtain additional financing in the future for working capital, capital expenditures, acquisitions, litigation, general corporate or other purposes may be limited;
|
|
|
•
|
a substantial portion of our cash flows from operations will be dedicated to the payment of the principal of our indebtedness as we are required to pay the principal amount of our convertible notes in cash upon conversion if specified conditions are met or when due;
|
|
|
•
|
if upon any conversion of our notes we are required to satisfy our conversion obligation with shares of our common stock or we are required to pay a “make-whole” premium with shares of our common stock, our existing stockholders’ interest in us would be diluted; and
|
|
|
•
|
we may be more vulnerable to economic downturns, less able to withstand competitive pressures and less flexible in responding to changing business and economic conditions.
|
|
|
•
|
our board of directors is authorized, without prior stockholder approval, to create and issue preferred stock, commonly referred to as “blank check” preferred stock, with rights senior to those of common stock;
|
|
|
•
|
our board of directors is staggered into two classes, only one of which is elected at each annual meeting;
|
|
|
•
|
stockholder action by written consent is prohibited;
|
|
|
•
|
nominations for election to our board of directors and the submission of matters to be acted upon by stockholders at a meeting are subject to advance notice requirements;
|
|
|
•
|
certain provisions in our bylaws and certificate of incorporation such as notice to stockholders, the ability to call a stockholder meeting, advance notice requirements and action of stockholders by written consent may only be amended with the approval of stockholders holding 66 2/3% of our outstanding voting stock;
|
|
|
•
|
our stockholders have no authority to call special meetings of stockholders; and
|
|
|
•
|
our board of directors is expressly authorized to make, alter or repeal our bylaws.
|
|
|
•
|
any current or future U.S. or foreign patent applications will be approved and not be challenged by third parties;
|
|
|
•
|
our issued patents will protect our intellectual property and not be challenged by third parties;
|
|
|
•
|
the validity of our patents will be upheld;
|
|
|
•
|
our patents will not be declared unenforceable;
|
|
|
•
|
the patents of others will not have an adverse effect on our ability to do business;
|
|
|
•
|
Congress or the U.S. courts or foreign countries will not change the nature or scope of rights afforded patents or patent owners or alter in an adverse way the process for seeking patents;
|
|
|
•
|
changes in law will not be implemented that will affect our ability to protect and enforce our patents and other intellectual property;
|
|
|
•
|
new legal theories and strategies utilized by our competitors will not be successful;
|
|
|
•
|
others will not independently develop similar or competing chip interfaces or design around any patents that may be issued to us; or
|
|
|
•
|
factors such as difficulty in obtaining cooperation from inventors, pre-existing challenges or litigation, or license or other contract issues will not present additional challenges in securing protection with respect to patents and other intellectual property that we acquire.
|
|
Period
|
Total Number
of Shares
Purchased
|
Total Number
of Shares
Purchased as
Publicly
Announced
Plans or
Programs
|
Total Paid
|
Average
Price Paid
per Share
|
Maximum
Number of
Shares that
May Yet be
Purchased
Under the
Plans or
Programs
|
|||||||||||||||
|
Cumulative shares repurchased as of 12/31/09
|
16,810,950 | 16,810,950 | $ | 233,756,155 | $ | 13.90 | 2,240,913 | |||||||||||||
|
Additional authorization
|
12,500,000 | |||||||||||||||||||
| 14,740,913 | ||||||||||||||||||||
|
2/1/2010-2/28/2010
|
1,233,287 | 1,233,287 | $ | 26,472,746 | $ | 21.47 | 13,507,626 | |||||||||||||
|
Cumulative shares repurchased as of 3/31/10
|
18,044,237 | 18,044,237 | $ | 260,228,901 | $ | 14.42 | ||||||||||||||
|
RAMBUS INC.
|
|
|
Date: April 30, 2010
|
|
|
By:
/s/ Satish Rishi
|
|
|
Satish Rishi
|
|
|
Senior Vice President, Finance and Chief Financial Officer
|
|
Exhibit
Number
|
Description of Document
|
|
3.1 (1)
|
Amended and Restated Certificate of Incorporation of Registrant filed May 29, 1997.
|
|
3.2 (2)
|
Certificate of Amendment of Amended and Restated Certificate of Incorporation of Registrant filed June 14, 2000.
|
|
3.3 (3)
|
Amended and Restated Bylaws of Registrant dated November 13, 2007.
|
|
10.1†
|
Settlement Agreement, dated January 19, 2010, among Registrant, Samsung Electronics Co., Ltd, Samsung Electronics America, Inc., Samsung Semiconductor, Inc. and Samsung Austin Semiconductor, L.P.
|
|
10.2†
|
Semiconductor Patent License Agreement, dated January 19, 2010, between Registrant and Samsung Electronics Co., Ltd.
|
|
10.3
|
Stock Purchase Agreement, dated January 19, 2010, between Registrant and Samsung Electronics Co., Ltd.
|
|
31.1
|
Certification of Principal Executive Officer, pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
31.2
|
Certification of Principal Financial Officer, pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
32.1
|
Certification of Principal Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
32.2
|
Certification of Principal Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
†
|
Confidential treatment has been requested with respect to certain portions of this exhibit. Omitted portions have been filed separately with the Securities and Exchange Commission.
|
|
(1)
|
Incorporated by reference to the Form 10-K filed on December 15, 1997.
|
|
(2)
|
Incorporated by reference to the Form 10-Q filed on May 4, 2001.
|
|
(3)
|
Incorporated by reference to the Form 10-Q filed on August 4, 2008.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|